ATE497784T1 - Arznei zur prävention und behandlung von herzerkrankungen mit cd9-gen - Google Patents
Arznei zur prävention und behandlung von herzerkrankungen mit cd9-genInfo
- Publication number
- ATE497784T1 ATE497784T1 AT04808124T AT04808124T ATE497784T1 AT E497784 T1 ATE497784 T1 AT E497784T1 AT 04808124 T AT04808124 T AT 04808124T AT 04808124 T AT04808124 T AT 04808124T AT E497784 T1 ATE497784 T1 AT E497784T1
- Authority
- AT
- Austria
- Prior art keywords
- gene
- heart diseases
- diseases
- drug
- heart
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Marine Sciences & Fisheries (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003432279 | 2003-12-26 | ||
PCT/JP2004/019774 WO2005063302A1 (ja) | 2003-12-26 | 2004-12-24 | Cd9遺伝子からなる心疾患を予防又は治療する医薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE497784T1 true ATE497784T1 (de) | 2011-02-15 |
Family
ID=34736470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04808124T ATE497784T1 (de) | 2003-12-26 | 2004-12-24 | Arznei zur prävention und behandlung von herzerkrankungen mit cd9-gen |
Country Status (6)
Country | Link |
---|---|
US (1) | US7803780B2 (de) |
EP (1) | EP1716869B1 (de) |
JP (1) | JP4736088B2 (de) |
AT (1) | ATE497784T1 (de) |
DE (1) | DE602004031381D1 (de) |
WO (1) | WO2005063302A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013200106B2 (en) * | 2006-04-21 | 2015-10-01 | Intervet International Bv | Pestivirus Species |
KR20200122601A (ko) * | 2019-04-18 | 2020-10-28 | 황정후 | Cd9을 이용한 퇴행성 신경질환의 예방 또는 치료용 조성물과 퇴행성 신경질환 치료제 스크리닝 방법 |
US11905249B2 (en) | 2021-01-25 | 2024-02-20 | Jackson State University | Covalent inhibitors of equine encephalitis virus |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0002922A3 (en) * | 1997-04-28 | 2003-03-28 | Aventis Pharma Sa | Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors |
US7060433B1 (en) * | 1999-11-12 | 2006-06-13 | Rigel Pharmaceuticals, Inc. | Methods and compositions for screening using diphtheria toxin constructs |
-
2004
- 2004-12-24 DE DE602004031381T patent/DE602004031381D1/de active Active
- 2004-12-24 JP JP2005516732A patent/JP4736088B2/ja not_active Expired - Fee Related
- 2004-12-24 AT AT04808124T patent/ATE497784T1/de not_active IP Right Cessation
- 2004-12-24 EP EP04808124A patent/EP1716869B1/de not_active Not-in-force
- 2004-12-24 US US10/584,109 patent/US7803780B2/en not_active Expired - Fee Related
- 2004-12-24 WO PCT/JP2004/019774 patent/WO2005063302A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005063302A1 (ja) | 2005-07-14 |
JP4736088B2 (ja) | 2011-07-27 |
US20070161584A1 (en) | 2007-07-12 |
JPWO2005063302A1 (ja) | 2007-07-19 |
EP1716869A4 (de) | 2007-05-23 |
EP1716869B1 (de) | 2011-02-09 |
EP1716869A1 (de) | 2006-11-02 |
US7803780B2 (en) | 2010-09-28 |
DE602004031381D1 (de) | 2011-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2187798T3 (es) | Procedimiento de conservacion de virus recombinantes infecciosos, suspension acuosa viral y su utilizacion como medicamento. | |
EP1497420A4 (de) | Mittel, die die aktivität und/oder expression von bindegewebe-wachstumsfaktor (ctgf) regulieren, hemmen oder modulieren, als einzigartige mittel sowohl zur senkung des augeninnendrucks als auch zur behandlung von glaukomatösen retinopathien/optischen neuropathien | |
CY1110400T1 (el) | Η χρηση της ρανολαζινης για την παρασκευη ενος φαρμακου για την θεραπεια των αρρυθμιων | |
CA2278842A1 (en) | Use of peroxygen compounds in the control of hairy wart disease | |
NO20044940L (no) | Rekombinant poxvirus som uttrykker homologe gener innsatt i det poxvirale genomet | |
DE60019473D1 (de) | (S,S)-Reboxetin zur Behandlung von peripheren Neuropathien | |
DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
DE60028863D1 (de) | Elektrochirurgisches Handstück zur Behandlung von Gewebe | |
ATE491715T1 (de) | Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten | |
DE602005020178D1 (de) | 5,6,7-trihydroxyheptansäure und analoge zur behandlung von augenkrankheiten und mit hyperproliferativen und angiogenen reaktionen verbundenen krankheiten | |
DE60009146D1 (de) | Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten | |
EP1343532A4 (de) | Durch lentiviralen vektor vermittelter gentransfer und anwendungszwecke | |
ATE497784T1 (de) | Arznei zur prävention und behandlung von herzerkrankungen mit cd9-gen | |
DE60231649D1 (de) | Mittel zur behandlung von augentrockenheit und damit zusammenhängenden erkrankungen | |
DE60231246D1 (de) | Superoxiddismutas-mimetika zur behandlung von augenerkrankungen | |
DE60111620D1 (de) | Aktiviertes protein c zur behandlung von pankreatitis | |
ATE330596T1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
AP9901474A0 (en) | Pharmaceutical composition for treating viral diseases. | |
DE60017174D1 (de) | Rivastigmine zur behandlung von augenerkrankungen | |
ATE343387T1 (de) | S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen. | |
ATE428436T1 (de) | Mittel zur behandlung oder prävention allergischer erkrankungen mit bearbeitetem erdnusssamen-überzug | |
DE50012667D1 (de) | Verwendung von 2-amino-3,4-dihydro-chinazolinen zur herstellung eines medikaments zur behandlung oder prophylaxe von ischämischen zuständen | |
FR2613621B1 (fr) | Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants | |
DE60009069D1 (de) | Bispidin-derivate zur behandlung von herzarrhythmien | |
Butler | Depression in the primary care practice. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |